TransMedics Group Quote, Financials, Valuation and Earnings

TransMedics Group Price Quote

+1.90 (+2.63%)
(Updated: June 2, 2023 at 7:50 PM ET)

TransMedics Group Key Stats

TransMedics Group (TMDX) is a Buy

Day range:
$70.87 - $72.47
52-week range:
$24.01 - $90.15
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does TransMedics Group Make?

Is TransMedics Group Growing As A Company?

  • What Is TransMedics Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.62%
  • What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TransMedics Group Stock Price Performance

  • Did TransMedics Group Stock Go Up Last Month?
    TransMedics Group share price went down by -7.22% last month
  • Did TMDX's Share Price Rise Over The Last Year?
    TMDX share price rose by 156.86% over the past 1 year

What Is TransMedics Group 52-Week High & Low?

TransMedics Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TransMedics Group?

  • How Much Debt Does TransMedics Group Have?
    Total long term debt quarterly is $58.8M
  • How Much Cash Does TransMedics Group Have?
    Cash and short term investments quarterly total is $195.4M
  • What Is TransMedics Group’s Book Value Per Share?
    Book value per share is 5.92

Is TransMedics Group Cash Flow Positive?

  • What Is TMDX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$36.1M
  • What Is TransMedics Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $171.5M
  • What Is TransMedics Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $43.1M

TransMedics Group Return On Invested Capital

  • Is Management Doing A Good Job?
    TMDX return on invested capital is -15.29%
  • What Is TransMedics Group Return On Assets?
    ROA measures how assets are converting to revenues and is -13.1%
  • What Is TMDX Return On Equity?
    ROE is a measure of profitability and is -20.85%

TransMedics Group Earnings Date & Stock Price

TransMedics Group Competitors

TransMedics Group Dividend Yield

Data Unavailable

TransMedics Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 67.58%
Revenue: 161.68% 9.57%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 90.20
Upside from Last Price: 24.88%

Major Shareholders

  • How many TMDX shares are owned by institutional investors?
    48.6M TMDX shares are owned by institutional investors
  • How many TMDX shares are owned by insiders?
    948.7K TMDX shares are owned by insiders